Viatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the ...

According to the letter, the facility's methods, controls, and overall operations failed to comply with Current Good ...

USFDA issued a warning letter to Glenmark Pharmaceuticals for significant CGMP violations at its Pithampur plant, including ...

Immediate support for the Nifty is seen in 24882. On the upside, unless 25255 is taken out decisively, traders should take a ...

The US health regulator has pulled up Glenmark Pharmaceuticals for manufacturing lapses, including failure to establish laboratory controls, at its Pithampur-based plant.      In a warning letter, the ...

Indian stock market benchmarks—the Sensex and the Nifty 50—ended lower on Friday, 18 July, extending losses for the third ...

On 21 July 2025, the Court of Appeal delivered a significant ruling in AstraZeneca AB & Anor v Generics (UK) Limited & Ors, ...

Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...

Imports of pharma raw materials worth Rs 1,362 crore have been avoided till March 2025 due to the creation of domestic ...

Dehradun: The owner of Dr Mittal Laboratories, which manufactured fake medicines by copying products of reputed pharmaceutical companies, was arrested on Friday in Uttarakhand.Devi Dayal Gupta, ...

The Nifty Pharma index closed 0.27 per cent down at 22531.85. Benchmark NSE Nifty50 index ended up 122.3 points at 25090.7, ...